Back to results
US 10,328,055 B2Granted
Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants
AssigneeGruenenthal GmbH
InventorsStefanie Frosch, Klaus Linz, Thomas Christoph
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient which is an antidepressant.
Claims4
A pharmaceutical composition comprising:
- a) a first pharmacologically active ingredient selected from the group consisting of a compound according to formula (I) and a physiologically acceptable salt thereof
- and
- b) a second pharmacologically active ingredient selected from the group consisting of duloxetine and a physiologically acceptable salt thereof,
- wherein the pharmaceutical composition is contained in a pharmaceutical dosage form,
- and wherein the relative weight ratio of the first pharmacologically active ingredient to the second pharmacologically active ingredient is within the range of from 1:10 to 1:5000.
2 more elements
Dependencies are inferred from the claim text.